Citadel Advisors’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-228,542
Closed -$3.46M 7216
2022
Q3
$3.46M Buy
228,542
+136,585
+149% +$2.07M ﹤0.01% 2201
2022
Q2
$690K Sell
91,957
-775
-0.8% -$5.82K ﹤0.01% 3808
2022
Q1
$844K Buy
92,732
+57,551
+164% +$524K ﹤0.01% 3914
2021
Q4
$247K Sell
35,181
-620,400
-95% -$4.36M ﹤0.01% 5302
2021
Q3
$7.47M Buy
655,581
+594,846
+979% +$6.78M ﹤0.01% 1697
2021
Q2
$972K Sell
60,735
-27,105
-31% -$434K ﹤0.01% 4044
2021
Q1
$1.57M Sell
87,840
-264,315
-75% -$4.72M ﹤0.01% 3449
2020
Q4
$4.76M Sell
352,155
-498,875
-59% -$6.74M ﹤0.01% 1820
2020
Q3
$10M Sell
851,030
-856,145
-50% -$10.1M ﹤0.01% 1111
2020
Q2
$25.2M Buy
1,707,175
+1,344,538
+371% +$19.8M 0.01% 655
2020
Q1
$4.9M Sell
362,637
-469,955
-56% -$6.34M ﹤0.01% 1460
2019
Q4
$20.1M Buy
832,592
+541,221
+186% +$13.1M 0.01% 793
2019
Q3
$5.6M Buy
291,371
+164,870
+130% +$3.17M ﹤0.01% 1583
2019
Q2
$3.74M Sell
126,501
-235,359
-65% -$6.95M ﹤0.01% 1885
2019
Q1
$17.2M Sell
361,860
-1,176,270
-76% -$55.9M 0.01% 821
2018
Q4
$55.5M Buy
1,538,130
+147,501
+11% +$5.32M 0.03% 287
2018
Q3
$85.6M Buy
1,390,629
+1,381,525
+15,175% +$85M 0.04% 249
2018
Q2
$615K Sell
9,104
-2,057
-18% -$139K ﹤0.01% 3005
2018
Q1
$606K Sell
11,161
-23,742
-68% -$1.29M ﹤0.01% 2796
2017
Q4
$2.09M Sell
34,903
-169,418
-83% -$10.1M ﹤0.01% 1876
2017
Q3
$9.93M Buy
204,321
+109,462
+115% +$5.32M 0.01% 935
2017
Q2
$4.99M Sell
94,859
-327,430
-78% -$17.2M ﹤0.01% 1199
2017
Q1
$19.2M Sell
422,289
-688,306
-62% -$31.2M 0.02% 624
2016
Q4
$42M Buy
1,110,595
+551,541
+99% +$20.9M 0.04% 235
2016
Q3
$21.1M Buy
+559,054
New +$21.1M 0.02% 491
2016
Q2
Sell
-12,917
Closed -$157K 4057
2016
Q1
$157K Buy
+12,917
New +$157K ﹤0.01% 2777
2015
Q4
Sell
-12,403
Closed -$220K 4405
2015
Q3
$220K Buy
12,403
+7,552
+156% +$134K ﹤0.01% 3122
2015
Q2
$86K Buy
+4,851
New +$86K ﹤0.01% 3310